Discontinuation report PEGETRON
Report ID | 5746 |
Drug Identification Number | 02246030 |
Brand name | PEGETRON |
Common or Proper name | ribavirin plus peginterferon alfa-2b, Powder for Solution in Vials |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PEGINTERFERON ALFA-2B RIBAVIRIN |
Strength(s) | 150MCG 200MG |
Dosage form(s) | CAPSULE POWDER FOR SOLUTION |
Route of administration | ORAL SUBCUTANEOUS |
Packaging size | vial |
ATC code | L03AB |
ATC description | IMMUNOSTIMULANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-04-04 |
Actual discontinuation date | 2017-04-04 |
Remaining supply date | 2017-04-04 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-04-05 | French | Compare |
v1 | 2017-04-05 | English | Compare |
Showing 1 to 2 of 2